Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Chou

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Pathology|October 11, 2023
Role of pathologists in nomogram development: replyYagiz A Aksoy, Angela Chou, Mahiar Mahjoub, et al.
ANZ Journal of Surgery|October 4, 2021
Sheep in wolf's clothing: squamoid cysts of the pancreatic ductsJuanita Noeline Chui, Krishna Kotecha, Grace Deng, et al.
Histopathology|June 20, 2020
When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most casesMatthew Zaborowski, Ana C Vargas, Jeremy Pulvers, et al.
The American Journal of Surgical Pathology|November 20, 2019
Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 PatientsTalia L Fuchs, Loretta Sioson, Amy Sheen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
ALK and ROS1 overexpression is very rare in colorectal adenocarcinomaMichelle Houang, Christopher W Toon, Adele Clarkson, et al.
European Journal of Clinical Investigation|April 8, 2025
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgerySooin Byeon, Bridget Abbott, Paul Roach, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2019
NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 casesAngela Chou, Tamara Fraser, Mahsa Ahadi, et al.
Plos One|February 8, 2014
Immunohistochemistry for myc predicts survival in colorectal cancerChristopher W Toon, Angela Chou, Adele Clarkson, et al.
Endocrine Pathology|October 21, 2023
A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?John Turchini, Talia L Fuchs, Angela Chou, et al.
Cancer Medicine|August 3, 2023
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapySumit Sahni, Christopher Nahm, Mahsa S Ahadi, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Pathology|October 11, 2023
Role of pathologists in nomogram development: replyYagiz A Aksoy, Angela Chou, Mahiar Mahjoub, et al.
ANZ Journal of Surgery|October 4, 2021
Sheep in wolf's clothing: squamoid cysts of the pancreatic ductsJuanita Noeline Chui, Krishna Kotecha, Grace Deng, et al.
Histopathology|June 20, 2020
When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most casesMatthew Zaborowski, Ana C Vargas, Jeremy Pulvers, et al.
The American Journal of Surgical Pathology|November 20, 2019
Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 PatientsTalia L Fuchs, Loretta Sioson, Amy Sheen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
ALK and ROS1 overexpression is very rare in colorectal adenocarcinomaMichelle Houang, Christopher W Toon, Adele Clarkson, et al.
European Journal of Clinical Investigation|April 8, 2025
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgerySooin Byeon, Bridget Abbott, Paul Roach, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2019
NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 casesAngela Chou, Tamara Fraser, Mahsa Ahadi, et al.
Plos One|February 8, 2014
Immunohistochemistry for myc predicts survival in colorectal cancerChristopher W Toon, Angela Chou, Adele Clarkson, et al.
Endocrine Pathology|October 21, 2023
A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?John Turchini, Talia L Fuchs, Angela Chou, et al.
Cancer Medicine|August 3, 2023
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapySumit Sahni, Christopher Nahm, Mahsa S Ahadi, et al.
Pageof 12